Incidence of Postoperative Residual Neuromuscular Blockade in the Era of Sugammadex
Recruiting
- Conditions
- Postoperative Residual Curarization
- Registration Number
- NCT05760560
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
This study is a prospective observational study. A total 52 patients will be included in this study. We will observe the incidence of postoperative residual neuromuscular blockade in patients receiving sugammadex.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 52
Inclusion Criteria
- Patients undergoing elective surgery under general anesthesia.
- American Society of Anesthesiologists grade 1, 2, or 3.
- Aged >18 years
Read More
Exclusion Criteria
- Refusal to participate in the study
- Body Mass Index < 18.5 kg/m2 or > 35 kg/m2
- History of neuromuscular disease.
- History of allergy to neuromuscular blockade
- Scheduled to transfer to the intensive care unit
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postoperative residual neuromuscular blockade On the arrival of PACU TOF ratio \< 0.9
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Seoul National University Bundang Hospital
🇰🇷Seongnam, Gyeonggi-do, Korea, Republic of